Intrinsiqq
Dolby Laboratories Inc. logo

Dolby Laboratories Inc. Quality Score

DLB

⊜ Compare
Quality64

Growth is the primary weakness (avg 35/100). Valuation is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
60/100
27.8x

25–30x, paying a growth premium

Cash Flow Multiple
90/100
15.7x

Under 20x cash flow, well covered

Revenue Growth
0/100
1.9%

Below 2%, essentially flat

Cash Flow Growth
70/100
9.8%

5–10% CAGR, steady but not exceptional

Business Quality & Capital Allocation

Share Dilution
100/100
-7.3%

Shrinking >2%, active buybacks

Margin Trend
90/100
+1.2pp

Expanded 1–3pp, steady progress

Capital Structure
100/100
-$623M

Net cash position, no leverage concern

2022
$809M
$51.0M
2023
$885M
$51.0M
2024
$482M
$47.0M
2025
$703M
$39.0M
TTM
$670M
$47.0M
CashDebt
Return on Capital
0/100
7.2%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Dolby Laboratories (DLB) quality: score, margins and returns

Dolby Laboratories (DLB) scores 64/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 17.7% operating margins and 7.2% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Dolby Laboratories (DLB) a high-quality business?+

Dolby Laboratories scores 64 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 17.7% operating margin and a 7.2% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Dolby Laboratories's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from DLB's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Dolby Laboratories scores well and where it falls behind.

What is Dolby Laboratories's return on invested capital (ROIC)?+

Dolby Laboratories earns about 7.2% on its invested capital, which is modest. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to DLB's margins and growth on this scorecard to judge durability.

How profitable is Dolby Laboratories?+

Dolby Laboratories runs an operating margin of about 17.7% and a net margin of about 16.7%. Revenue has grown at roughly 3.0% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 30 Jul 2026, covering the period ending 26 Jun 2026, as reported to the SEC. Data last refreshed 3 Oct 2026. How this is calculated.

Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Patent Owners & Lessors · Pick stocks to compare with DLB

CompareIntrinsic value
IDCCInterDigital, Inc.
$308.50-1.63%69
APPSDigital Turbine Inc.
$9.54+3.81%25
ACTGAcacia Research Corporation
$4.36+2.11%40
RLJRLJ Lodging Trust
$12.72+1.03%63
FRTFederal Realty Investment Trust
$114.63+2.68%76
BRXBrixmor Property Group Inc.
$30.23+2.79%56
OHIOmega Healthcare Investors Inc
$49.17+3.45%88
APLEApple Hospitality REIT, Inc.
$18.82+0.91%70

Held by ETFs

DLB is in 134 US ETFs. The largest of them, with DLB's weight in each:

Spot a number that looks wrong? Check it in DLB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DLB

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.